Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study

[Image: see text] Cabotegravir (CAB) is an integrase strand-transfer inhibitor of HIV that has proven effective for HIV treatment and prevention in a long-acting injectable formulation, typically preceded by an oral formulation lead-in phase. Previous in vitro studies have demonstrated that CAB is p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ACS Pharmacol Transl Sci
Päätekijät: Seneviratne, Herana Kamal, Hamlin, Allyson N., Li, Sue, Grinsztejn, Beatriz, Dawood, Halima, Liu, Albert Y., Kuo, Irene, Hosseinipour, Mina C., Panchia, Ravindre, Cottle, Leslie, Chau, Gordon, Adeyeye, Adeola, Rinehart, Alex R., McCauley, Marybeth, Eron, Joseph S., Cohen, Myron S., Landovitz, Raphael J., Hendrix, Craig W., Bumpus, Namandjé N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Chemical Society 2021
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7888308/
https://ncbi.nlm.nih.gov/pubmed/33615175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00181
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia